Feb 25, 2022 09:17AM
Oct 22, 2021 05:00PM
Mar 29, 2021 09:15AM
Feb 22, 2021 09:15AM
Jan 27, 2021 09:15AM
Jan 6, 2021 09:00AM
Nov 16, 2020 09:15AM Theralink® Technologies Announces Partnership with Perthera to Facilitate and Accelerate Access to its Unique Phosphoprotein and Drug Target Activation Testing in the U.S.
Sep 29, 2020 08:30AM
Sep 24, 2020 12:00PM
Jul 15, 2019 09:42AM
May 30, 2019 09:08AM
May 1, 2019 09:28AM
Feb 28, 2019 08:29AM
Nov 8, 2018 09:08AM OncBioMune Phase 2 Clinical Trial to Begin Enrollment; Company Announces Other Developments and Corporate Milestones
Oct 16, 2018 12:35PM
Oct 11, 2018 09:39AM
Oct 11, 2018 09:36AM
Sep 27, 2018 09:54AM
Sep 27, 2018 09:51AM
Jul 2, 2018 02:37PM
Feb 28, 2018 08:29AM OncBioMune Submits Phase 2 Protocol to Urology Centers of North Texas
Feb 26, 2018 12:47PM
Aug 31, 2017 08:38AM
Aug 24, 2017 08:32AM
Aug 3, 2017 09:12AM
Jul 13, 2017 08:30AM
Jun 1, 2017 08:30AM
May 9, 2017 11:28AM OncBioMune Provides Corporate Update, Nearly 50 Drug Candidates in Pipeline or Being Negotiated
May 3, 2017 12:23PM
Apr 18, 2017 03:10PM
Jan 26, 2017 03:47PM

324,852 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All